Guidant Focused On Trend Thresholds Instead Of Preventable Deaths – Panel

Guidant has relied too much on engineers and not enough on physicians in evaluating the postmarket performance of its implantable cardiac rhythm management products, making it possible for device problems to go unaddressed, according to an expert panel commissioned by the company

More from Archive

More from Medtech Insight